{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "7Agenus, Boston, MA, USA",
    "1 Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA",
    "9 Agenus Inc, Lexington, Massachusetts, USA",
    "1Agenus Inc., Lexington, MA, USA",
    "1MiNK Therapeutics, Lexington, MA, USA",
    "2Agenus, Lexington, MA, USA",
    "MiNK Therapeutics, Lexington, MA, USA",
    "Isosceles Pharmaceuticals, Wilmington, NC, USA",
    "Agenus Inc., Lexington, MA, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 11,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Nils-Petter Rudqvist"
    },
    {
      "affs": [
        1
      ],
      "name": "Bishnu Joshi"
    },
    {
      "affs": [
        2
      ],
      "name": "Dhan Chand"
    },
    {
      "affs": [
        3
      ],
      "name": "Benjamin Morin"
    },
    {
      "affs": [
        4
      ],
      "name": "Reed Masakayan"
    },
    {
      "affs": [
        5
      ],
      "name": "Shanmugarajan Krishnan"
    },
    {
      "affs": [
        6
      ],
      "name": "Olivier Le Tonqueze"
    },
    {
      "affs": [
        7
      ],
      "name": "Robert B Stein"
    },
    {
      "affs": [
        8
      ],
      "name": "Justin G Keith"
    },
    {
      "affs": [
        6
      ],
      "name": "Nick Kushner"
    },
    {
      "affs": [
        8
      ],
      "name": "John Chamberland"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/21phdmrc0mj7m.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0270",
  "fulltext_url": null,
  "id": "21phdmrc0mj7m",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0270",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225164722",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A304.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/21phdmrc0mj7m.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T14:21:08Z",
      "native_id": "5b56d34de8ec4518b04b073ad60b8ce4",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0270"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "270 AgenT-797, an allogeneic iNKT cell therapy, enables tumor-cell killing in a human organoid model of immune checkpoint inhibitor–refractory colorectal cancer liver metastases",
  "title_text": "270 AgenT-797, an allogeneic iNKT cell therapy, enables tumor-cell killing in a human organoid model of immune checkpoint inhibitor–refractory colorectal cancer liver metastases",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T14:20:35Z",
  "url": "https://research.draconitic.com/paper/21phdmrc0mj7m",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}